U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Office of Pharmaceutical Quality (OPQ) Reorganization - 07/11/2024
  1. News & Events for Human Drugs

Virtual | Virtual

Event Title
Office of Pharmaceutical Quality (OPQ) Reorganization
July 11, 2024

Date:
July 11, 2024

Visit CDER Small Business and Industry Assistance Page

ABOUT THIS EVENT (Hosted by CDER SBIA)

FDA is announcing a webinar on the reorganization of the Center for Drug Evaluation and Research’s (CDER) Office of Pharmaceutical Quality (OPQ). This reorganization was implemented in January and does not result in any direct or immediate changes for external groups, including drug manufacturers.

This reorganization enables OPQ to evolve and adapt to the ever-changing global healthcare landscape and:

  • Streamline processes and systems for enhanced efficiency, eliminating operational redundancies and bottlenecks.
  • Embrace new technologies and tools as the key to staying ahead in a dynamic environment.
  • Actively pursue innovation to make a meaningful difference in patients' lives.
  • Adopt a culture of continuous improvement, in which OPQ is consistently seeking better and more efficient ways of working and advancing the field.

OPQ restructured to increase the ability to respond to changes in workload, increasing complexity of pharmaceutical supply chains, and public health emergencies. OPQ created five new offices to allow quick response to demands and public health needs and allow for an integrated quality assessment of products throughout their lifecycle. This webinar describes the new structure of OPQ and how it continues to advance the quality of drugs.

Back to Top